QTMeds

Drug Database Monograph

ULTOMIRIS 1100 mg/11 mL

PENDING REVIEW

Active Ingredient: RAVULIZUMAB

QTc Interval Status:

neutral

Clinical Description (Database Summary)

Scientific Sources / References

Analyse RCP (Automatique), id : 64265627

← Back to Prescription Analyzer